Delivery Order SPE2DB22D3401-SPE2DB24FT3PY

Award Date 6/26/24
Potential Completion Date 6/27/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,141.00 firm fixed-price delivery order contract is for the supply of SKYRIZI 150 MG/ML PENML, a specialty medication. The contract has an ultimate completion date of November 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of SKYRIZI 150 MG/ML PENML, a pharmaceutical product. The firm-fixed-price delivery order, valued at $16,417.53, has a period of performance through March 26, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $12,236.27 firm fixed-price delivery order is for the supply of SKYRIZI 150 MG/ML PENML, with a completion date of December 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $46,765.40, is for the delivery of SKYRIZI 150 MG/ML PENML, a medical product, with an ultimate completion date of April 8, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,568.31, is for the delivery of SKYRIZI 150 MG/ML PENML, a specialty pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of September 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $76,698.42 Firm Fixed Price delivery order is for the drug SKYRIZI 150 MG/ML PENML. The contract has an ultimate completion date of March 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award is between the Defense Logistics Agency (DLA) and AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,827.51 firm fixed-price delivery order is for the supply of SKYRIZI 150 MG/ML PENML, a specialty medication. The contract has a completion date of November 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $77,040.74, is for the delivery of SKYRIZI 150 MG/ML PENML, a pharmaceutical product. The contract has a firm fixed price and the ultimate completion date is October 16, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,309.04, is a Firm Fixed Price Delivery Order for the pharmaceutical product SKYRIZI 150 MG/ML PENML. The contract has an ultimate completion date of May 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, for the delivery of SKYRIZI 150 MG/ML PENML medical supplies. The contract, valued at $47,605.25, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC is valued at up to $999,999,999.00 and runs through November 2026, serving as the primary vehicle...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB24FT3PY
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of SKYRIZI 150 MG/ML PENML medication. The contract has a ceiling value of $11,827.51 and an ultimate completion date of June 27, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, Amerisourcebergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

The contract does not have a set-aside designation, indicating that it was awarded on a full and open competition basis. As a subsidiary of one of the largest pharmaceutical distribution companies in the world, Amerisourcebergen leverages its extensive supply chain network to efficiently fulfill government contracts for critical medical products.

Generated 9/25/24, 9:31 AM